Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial
Abstract
In this rural African setting, pneumococcal conjugate vaccine has high efficacy against radiological pneumonia and invasive pneumococcal disease, and can substantially reduce admissions and improve child survival. Pneumococcal conjugate vaccines should be made available to African infants.
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
non-u.s. gov't
u.s. gov't
non-p.h.s.
female
male
Child
Infant
P.H.S.
preschool
Clinical Trial
Randomized Controlled Trial
Multicenter Study
Incidence
pneumonia
vaccines
pneumococcal infections / diagnosis
immunization schedule
pneumococcal infections / prevention & control*
pneumococcal / diagnosis
pneumococcal / epidemiology
conjugate
f t cutts
pmid:15794968
doi:10.1016/s0140-6736(05)71876-6
s m a zaman
gambian pneumococcal vaccine trial group
gambia / epidemiology
pneumococcal infections / epidemiology
pneumococcal vaccines / administration & dosage*
pneumococcal vaccines / adverse effects
pneumococcal / prevention & control*
Access
Citation
ID:
117567
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
117567
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet
